Maintaining good biosecurity for shrimp farmers isn’t just an operational task; it’s a critical measure to protect the health of their stock, preserve productivity, and safeguard investment. Implementing highly accurate pathogen testing can make all the difference in mitigating risk and ensuring the long-term success of shrimp farms.

Genics Shrimp MultiPath allows farmers to act with confidence, protecting their investment, surrounding environments, and the integrity of local shrimp populations.

The Risks of Inadequate Testing in Quarantine Procedures 

Without rigorous pathogen testing, shrimp farms (and production systems) expose themselves to significant risks. Shrimp pathogens — including viruses, bacteria and microsporidia — can spread rapidly within and between farms, leading to costly outbreaks that can devastate operations. Comprehensive early detection is particularly vital in the quarantine phase, where any pathogens present in new stock can be identified and the biosecurity risk managed before spreading further.

Steve Arce, Global Technical Manager for Shrimp BU at Hendrix Genetics, emphasizes that current mandatory testing requirements (while helpful) may not be enough given the evolving nature of pathogens and variations in testing standards between countries.

“Each country is at different levels,” he explains.

“The need is there to apply more rigorous application in terms of proper PCR techniques and understanding of the pathogens of concern.”

This evolving landscape requires farms to think beyond compliance, prioritizing thorough testing to safeguard their biosecurity and ensure dangerous pathogens don’t slip through the cracks.

Real-World Benefits of Comprehensive Testing 

For Atlantic Shrimpers, a shrimp farming operation based in Nigeria, additional pathogen testing in quarantine has become standard practice. Project Manager Françoise Pironet shares that they encountered a pathogen, LSNV, in their stock despite the broodstock passing supplier-provided tests.

“Our suppliers test batches before shipment, but we use Shrimp MultiPath as a second line of defence,” Pironet explains.

“Without it, we wouldn’t have detected LSNV in the batch of broodstock, which could have spread throughout our entire stock.” This additional layer of screening prevented a potentially damaging outbreak, saving Atlantic Shrimpers from significant financial and operational impacts.

Similarly, on an isolated island farm in Seychelles, Islands Development Company’s Fisheries & Aquaculture Development Manager, Riaz Aumeeruddy, oversees strict testing protocols.

“The accuracy and sensitivity of pathogen testing are of major importance for our farm,” Aumeeruddy explains.

The island’s isolation amplifies the importance of preventing any pathogens from entering the farm, as the spread to surrounding oceanic waters would jeopardize both the farm and the local ecosystem. By placing new shrimp larvae in quarantine until all pathogen tests return negative, Aumeeruddy and his team are implementing best-practice and doing everything they can to have a high-level of confidence to introduce only healthy stock to grow-out ponds.

“With Shrimp MultiPath, we are confident we are screening as comprehensively as possible,” he adds.

Going Above and Beyond: The Value of Highly Sensitive Testing

The experiences of Atlantic Shrimpers and Islands Development Company highlight a crucial point for shrimp farmers worldwide: going beyond standard testing requirements is an investment that protects the long-term viability of their farms. Routine pathogen screening that uses sensitive, accurate methods enables farms to detect even trace levels of pathogens. This level of scrutiny, often above and beyond what regulations require, provides essential security.

Steve Arce recommends a similar approach for the industry, particularly for quarantine testing.

“Routine screening of all shrimp stocks with statistically significant sample sizes provides at least 98% confidence in health status,” he suggests.

In his experience, adding these practices and employing Shrimp MultiPath alongside histopathology significantly reduces the risk of pathogens going undetected. By investing in testing practices that ensure pathogen detection at the earliest stage, farmers can stop potential outbreaks before they start, preserving farm productivity and profitability.

MultiPath testing provides qualitative and quantitative data, giving farmers a clear picture of the pathogen load in their stock. For shrimp farmers, this detailed insight translates to better decision-making and the ability to implement timely interventions, protecting both their stock and their investment.

As Pironet describes “Genics [MultiPath testing] doesn’t just identify pathogens but also allows us to develop the best strategy tailored to our needs.

“This service goes beyond basic testing and helps us make informed decisions that protect our operation.”

Reducing the Spread of Emerging Pathogens 

The shrimp industry faces an ever-present challenge of emerging pathogens and changes in existing pathogen strains.

As Arce points out, “It’s not the pathogens we know of now that pose the greatest threat, but the yet-to-be-identified pathogens which should be considered and proactively addressed.”

With the rapid movement of live shrimp stock across countries, farms are at constant risk of encountering new pathogens. A highly sensitive testing approach allows farms to screen comprehensively for known and emerging threats, protecting the health of their current stock while preventing the spread to other farms.

Case for Best Practices in Pathogen Testing

For shrimp farmers, investing in highly accurate, sensitive pathogen testing isn’t just about protecting a single crop; it’s about preserving the entire operation and, ultimately, the future of their farm.

By integrating MultiPath into their testing protocols, farms like Atlantic Shrimpers are able to detect pathogens like LSNV in imported broodstock, where other tests failed, minimizing the risk of outbreaks.

 “The cost of Genics Shrimp MultiPath testing is worthwhile. Additional screening ensures that each batch that arrives is safe, significantly reducing the risk of a disease outbreak.”

For isolated farms like Islands Development Company in Seychelles, additional testing supports the entire ecosystem in which they operate, ensuring that farms contribute to sustainable shrimp production rather than creating vulnerabilities.

Incorporating thorough, statistically significant testing in quarantine practices gives farmers confidence in their stock’s health, while also setting a high standard for biosecurity across the shrimp industry. In a world where pathogens are constantly evolving, the importance of sensitive and accurate testing before translocation or movement cannot be overstated.

If you are receiving stock into your production facility or farm from another location or country, Shrimp MultiPath quarantine testing is here to protect your investment.

Want to know more about Shrimp MultiPath2.0?  

Get all the information you need and book a free consultation with Dr. Melony Sellars today.

We would like to wish you a Merry Christmas and a very Happy Holiday. From our family to yours, thank you for your dedication and commitment throughout 2022.

We love working with you on early pathogen detection, risk mitigation and on your breeding programs.

This year we’ve seen great success throughout Ecuador, Indonesia, Vietnam and abroad. The impacts that we are having in terms of early pathogen detection and breeding programs are phenomenal.

Thank you.

Merry Christmas and Happy New Year!
Team Genics.

Genics participate in regular compliance testing such as the Australian ISO17043 accredited PT Program for Crustaceans as part of our Quality Assurance Procedures. Most recently the Genics Laboratory Teams passed their WSSV and YHV PT testing. Participating in these programs is one part of the Compliance Process which provides our clients with confidence in their data from Shrimp MultiPathTM on which to make data driven farm management decisions.

Genics is growing fast and we’re seeking an AQUATIC VETERINARIAN based in Brisbane, Australia. This is an opportunity to build and lead our diagnostic team working with clients all over the world. Reporting to the Genics CEO and working closely with our R&D Team, it’s a great opportunity to showcase your skills in biosecurity, development of disease & health management plans and educate farmers on the importance of early pathogen detection for risk mitigation and improved crop yield.